Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amblyopia | 12 | 2023 | 143 | 5.680 |
Why?
|
Optic Neuropathy, Ischemic | 9 | 2023 | 73 | 5.170 |
Why?
|
Fluorescein Angiography | 10 | 2022 | 940 | 2.580 |
Why?
|
Optic Disk | 7 | 2019 | 400 | 2.530 |
Why?
|
Tomography, Optical Coherence | 12 | 2022 | 2657 | 2.390 |
Why?
|
Copper | 6 | 2014 | 366 | 2.280 |
Why?
|
Retinal Vessels | 6 | 2021 | 772 | 2.030 |
Why?
|
Mixed Function Oxygenases | 5 | 2014 | 272 | 1.750 |
Why?
|
Giant Cell Arteritis | 3 | 2022 | 292 | 1.680 |
Why?
|
Pseudotumor Cerebri | 3 | 2023 | 100 | 1.630 |
Why?
|
Papilledema | 3 | 2023 | 118 | 1.570 |
Why?
|
Multienzyme Complexes | 5 | 2014 | 686 | 1.490 |
Why?
|
Ciliary Arteries | 3 | 2021 | 17 | 1.430 |
Why?
|
Visual Acuity | 16 | 2023 | 2530 | 1.430 |
Why?
|
Retinal Diseases | 3 | 2021 | 683 | 1.390 |
Why?
|
Retinal Artery Occlusion | 2 | 2021 | 74 | 1.340 |
Why?
|
Optic Nerve Diseases | 3 | 2023 | 327 | 1.230 |
Why?
|
Vision Disorders | 6 | 2022 | 1058 | 1.230 |
Why?
|
Ophthalmology | 4 | 2022 | 508 | 1.130 |
Why?
|
Retinal Artery | 2 | 2017 | 111 | 1.130 |
Why?
|
Amygdala | 4 | 2014 | 1315 | 1.040 |
Why?
|
Choroid Diseases | 2 | 2022 | 66 | 0.950 |
Why?
|
Eye Injuries | 2 | 2024 | 245 | 0.920 |
Why?
|
Esotropia | 1 | 2024 | 91 | 0.870 |
Why?
|
Video Games | 2 | 2023 | 184 | 0.840 |
Why?
|
Eye Injuries, Penetrating | 2 | 2022 | 115 | 0.810 |
Why?
|
Meningitis, Cryptococcal | 1 | 2022 | 63 | 0.810 |
Why?
|
Optic Disk Drusen | 2 | 2019 | 35 | 0.780 |
Why?
|
Orbital Myositis | 1 | 2021 | 20 | 0.780 |
Why?
|
Choroid | 2 | 2022 | 322 | 0.770 |
Why?
|
Coloboma | 2 | 2018 | 54 | 0.760 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2020 | 245 | 0.760 |
Why?
|
Fovea Centralis | 1 | 2021 | 119 | 0.760 |
Why?
|
Visual Fields | 5 | 2018 | 1047 | 0.750 |
Why?
|
Eye Diseases | 2 | 2023 | 669 | 0.740 |
Why?
|
Duane Retraction Syndrome | 1 | 2021 | 60 | 0.740 |
Why?
|
Spinocerebellar Ataxias | 1 | 2021 | 91 | 0.730 |
Why?
|
Muscle Spasticity | 1 | 2021 | 154 | 0.730 |
Why?
|
Intracranial Hypertension | 1 | 2022 | 186 | 0.720 |
Why?
|
Strabismus | 1 | 2024 | 287 | 0.710 |
Why?
|
Chorea | 1 | 2020 | 74 | 0.700 |
Why?
|
Scotoma | 2 | 2017 | 139 | 0.690 |
Why?
|
Microvessels | 2 | 2021 | 544 | 0.690 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2016 | 46 | 0.690 |
Why?
|
Optic Atrophy | 1 | 2020 | 79 | 0.680 |
Why?
|
Zinc | 2 | 2014 | 684 | 0.670 |
Why?
|
Vitreous Body | 1 | 2020 | 389 | 0.660 |
Why?
|
Vision, Ocular | 2 | 2021 | 464 | 0.660 |
Why?
|
Orbital Fractures | 1 | 2019 | 110 | 0.650 |
Why?
|
Optic Nerve Neoplasms | 1 | 2018 | 44 | 0.630 |
Why?
|
Metabolism, Inborn Errors | 1 | 2020 | 288 | 0.610 |
Why?
|
Anophthalmos | 1 | 2017 | 22 | 0.600 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2020 | 157 | 0.600 |
Why?
|
Synaptic Transmission | 3 | 2014 | 1178 | 0.590 |
Why?
|
Neuromyelitis Optica | 1 | 2021 | 252 | 0.590 |
Why?
|
Retinal Telangiectasis | 1 | 2016 | 24 | 0.570 |
Why?
|
Angiography | 2 | 2022 | 1639 | 0.570 |
Why?
|
Conjunctival Neoplasms | 1 | 2017 | 79 | 0.560 |
Why?
|
Retinal Vein Occlusion | 1 | 2017 | 137 | 0.540 |
Why?
|
Visual Field Tests | 4 | 2018 | 383 | 0.520 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 882 | 0.510 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 262 | 0.510 |
Why?
|
Homozygote | 1 | 2020 | 1785 | 0.510 |
Why?
|
Lyme Disease | 1 | 2021 | 621 | 0.510 |
Why?
|
Retina | 3 | 2022 | 2616 | 0.500 |
Why?
|
Optic Nerve | 1 | 2017 | 554 | 0.480 |
Why?
|
Vision, Binocular | 4 | 2024 | 213 | 0.480 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 509 | 0.470 |
Why?
|
Optic Neuritis | 1 | 2015 | 166 | 0.460 |
Why?
|
Autistic Disorder | 1 | 2023 | 1185 | 0.460 |
Why?
|
Conjunctiva | 1 | 2017 | 494 | 0.460 |
Why?
|
Hemangioma | 1 | 2018 | 738 | 0.440 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2915 | 0.410 |
Why?
|
Sensory Deprivation | 3 | 2023 | 109 | 0.410 |
Why?
|
Diplopia | 2 | 2024 | 200 | 0.390 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1596 | 0.380 |
Why?
|
Nerve Fibers | 3 | 2019 | 687 | 0.370 |
Why?
|
Eye | 3 | 2023 | 729 | 0.350 |
Why?
|
Humans | 53 | 2024 | 744343 | 0.330 |
Why?
|
Oculomotor Muscles | 2 | 2024 | 371 | 0.330 |
Why?
|
Interneurons | 1 | 2013 | 577 | 0.330 |
Why?
|
Fear | 2 | 2014 | 1440 | 0.320 |
Why?
|
Neuronal Plasticity | 4 | 2022 | 1422 | 0.310 |
Why?
|
Proteins | 2 | 2020 | 6103 | 0.300 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3176 | 0.270 |
Why?
|
Arteritis | 2 | 2018 | 159 | 0.260 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1587 | 0.260 |
Why?
|
Genetic Testing | 2 | 2017 | 3444 | 0.260 |
Why?
|
Mutation | 5 | 2021 | 29786 | 0.250 |
Why?
|
Synapses | 4 | 2017 | 1728 | 0.240 |
Why?
|
Capillaries | 2 | 2017 | 773 | 0.240 |
Why?
|
Long-Term Potentiation | 2 | 2014 | 293 | 0.210 |
Why?
|
Orthoptics | 1 | 2021 | 10 | 0.210 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2022 | 68 | 0.210 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 770 | 0.210 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 22 | 0.200 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4034 | 0.200 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 817 | 0.190 |
Why?
|
Cation Transport Proteins | 2 | 2014 | 327 | 0.190 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2024 | 349 | 0.180 |
Why?
|
Blepharoptosis | 1 | 2021 | 143 | 0.180 |
Why?
|
Eye Evisceration | 1 | 2019 | 23 | 0.180 |
Why?
|
Eye Enucleation | 1 | 2019 | 128 | 0.180 |
Why?
|
Adenosine Triphosphatases | 2 | 2014 | 839 | 0.170 |
Why?
|
Carotid Artery, Internal | 1 | 2021 | 445 | 0.170 |
Why?
|
Bone Density | 1 | 2012 | 3468 | 0.170 |
Why?
|
Middle Aged | 13 | 2022 | 213383 | 0.170 |
Why?
|
Eyelids | 1 | 2021 | 265 | 0.160 |
Why?
|
Orbit | 1 | 2022 | 426 | 0.160 |
Why?
|
Male | 19 | 2022 | 350118 | 0.160 |
Why?
|
Health Status | 1 | 2012 | 4034 | 0.160 |
Why?
|
Emotions | 1 | 2010 | 2661 | 0.160 |
Why?
|
Uveal Diseases | 1 | 2018 | 45 | 0.160 |
Why?
|
Retinal Detachment | 1 | 2022 | 411 | 0.160 |
Why?
|
Pupil Disorders | 1 | 2018 | 33 | 0.160 |
Why?
|
Glutarates | 1 | 2020 | 236 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
Edema | 1 | 2022 | 789 | 0.150 |
Why?
|
Muscle Relaxants, Central | 1 | 2018 | 86 | 0.150 |
Why?
|
Female | 19 | 2024 | 380194 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2021 | 402 | 0.150 |
Why?
|
Aged | 10 | 2022 | 163280 | 0.150 |
Why?
|
Heterozygote | 2 | 2014 | 2804 | 0.150 |
Why?
|
Patch-Clamp Techniques | 4 | 2014 | 964 | 0.140 |
Why?
|
Ophthalmoscopy | 1 | 2017 | 176 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 254 | 0.140 |
Why?
|
Fundus Oculi | 1 | 2017 | 473 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2017 | 520 | 0.140 |
Why?
|
Optic Atrophy, Autosomal Dominant | 1 | 2015 | 9 | 0.130 |
Why?
|
Corneal Diseases | 1 | 2022 | 636 | 0.130 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.130 |
Why?
|
Siblings | 1 | 2020 | 854 | 0.130 |
Why?
|
Adult | 11 | 2024 | 214055 | 0.130 |
Why?
|
Vision, Low | 1 | 2017 | 168 | 0.130 |
Why?
|
Child, Preschool | 6 | 2023 | 41006 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.130 |
Why?
|
Leukemia | 1 | 2023 | 1511 | 0.130 |
Why?
|
Pentylenetetrazole | 1 | 2014 | 69 | 0.120 |
Why?
|
GABA Antagonists | 1 | 2014 | 128 | 0.120 |
Why?
|
trans-Golgi Network | 1 | 2013 | 33 | 0.120 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.120 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39050 | 0.120 |
Why?
|
Animals | 11 | 2023 | 168757 | 0.120 |
Why?
|
Tissue Culture Techniques | 1 | 2014 | 290 | 0.110 |
Why?
|
Subcellular Fractions | 1 | 2013 | 547 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4186 | 0.110 |
Why?
|
Catecholamines | 1 | 2013 | 387 | 0.110 |
Why?
|
Autoantibodies | 1 | 2021 | 2035 | 0.110 |
Why?
|
Hippocampus | 3 | 2014 | 3675 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 689 | 0.110 |
Why?
|
Electrophysiology | 3 | 2010 | 1308 | 0.100 |
Why?
|
Pedigree | 1 | 2020 | 4644 | 0.100 |
Why?
|
Child | 8 | 2023 | 77709 | 0.100 |
Why?
|
Pyramidal Cells | 1 | 2014 | 363 | 0.100 |
Why?
|
Mice | 6 | 2023 | 81183 | 0.090 |
Why?
|
Hematocrit | 1 | 2012 | 636 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1866 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2016 | 1530 | 0.090 |
Why?
|
Diazepam | 1 | 2010 | 205 | 0.090 |
Why?
|
Neural Inhibition | 1 | 2014 | 602 | 0.090 |
Why?
|
Membrane Potentials | 2 | 2010 | 1137 | 0.090 |
Why?
|
Ultrasonography | 2 | 2019 | 5985 | 0.090 |
Why?
|
Signal Transduction | 1 | 2012 | 23403 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1941 | 0.080 |
Why?
|
Visual Cortex | 1 | 2017 | 1149 | 0.080 |
Why?
|
Behavior, Animal | 2 | 2014 | 1881 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2017 | 2564 | 0.080 |
Why?
|
Thalamus | 1 | 2014 | 1023 | 0.080 |
Why?
|
Muscle Strength | 1 | 2012 | 592 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12959 | 0.080 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2008 | 377 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.070 |
Why?
|
Frail Elderly | 1 | 2012 | 693 | 0.070 |
Why?
|
Biogenic Amines | 1 | 2006 | 50 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2203 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 21827 | 0.070 |
Why?
|
Pain | 1 | 2022 | 4986 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2023 | 63114 | 0.070 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.070 |
Why?
|
Glaucoma | 1 | 2015 | 1159 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20129 | 0.060 |
Why?
|
DNA | 2 | 2021 | 7301 | 0.060 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2008 | 581 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
Risk Factors | 3 | 2023 | 72290 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2010 | 6365 | 0.060 |
Why?
|
Gap Junctions | 1 | 2006 | 233 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2454 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.060 |
Why?
|
Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
Acetylcholinesterase | 1 | 2023 | 153 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3340 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 824 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2418 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2006 | 647 | 0.050 |
Why?
|
Eye Pain | 1 | 2022 | 47 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2017 | 7880 | 0.050 |
Why?
|
Ion Channels | 1 | 2006 | 1056 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9734 | 0.050 |
Why?
|
Seizures | 1 | 2014 | 2859 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2014 | 3297 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2014 | 14557 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3079 | 0.050 |
Why?
|
Eyeglasses | 1 | 2021 | 145 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2013 | 19229 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5708 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 306 | 0.040 |
Why?
|
Lighting | 1 | 2020 | 231 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11366 | 0.040 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 397 | 0.040 |
Why?
|
Anxiety | 1 | 2010 | 4297 | 0.030 |
Why?
|
Confidentiality | 1 | 2020 | 612 | 0.030 |
Why?
|
Diet | 1 | 2014 | 7939 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1387 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2174 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
Documentation | 1 | 2020 | 871 | 0.030 |
Why?
|
Cohort Studies | 2 | 2016 | 40561 | 0.030 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.030 |
Why?
|
Muscles | 2 | 2006 | 1614 | 0.020 |
Why?
|
Managed Care Programs | 1 | 2016 | 950 | 0.020 |
Why?
|
Neurons | 2 | 2008 | 9338 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3064 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35421 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Silver Staining | 1 | 2008 | 64 | 0.020 |
Why?
|
Synaptophysin | 1 | 2008 | 141 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3396 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2008 | 270 | 0.020 |
Why?
|
Avoidance Learning | 1 | 2008 | 233 | 0.020 |
Why?
|
Palinuridae | 1 | 2006 | 2 | 0.020 |
Why?
|
Octopamine | 1 | 2006 | 40 | 0.020 |
Why?
|
Ganglia, Invertebrate | 1 | 2006 | 24 | 0.020 |
Why?
|
Maze Learning | 1 | 2008 | 478 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 712 | 0.020 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2006 | 39 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3229 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5853 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 485 | 0.020 |
Why?
|
Oscillometry | 1 | 2006 | 147 | 0.020 |
Why?
|
Microelectrodes | 1 | 2006 | 303 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2006 | 327 | 0.020 |
Why?
|
Biophysics | 1 | 2006 | 383 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 13881 | 0.020 |
Why?
|
Potassium Channels | 1 | 2006 | 563 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2726 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1017 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2006 | 691 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
United States | 2 | 2022 | 69872 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2327 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2006 | 1767 | 0.010 |
Why?
|
Motor Neurons | 1 | 2006 | 844 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2006 | 852 | 0.010 |
Why?
|
Dopamine | 1 | 2006 | 1591 | 0.010 |
Why?
|
Movement | 1 | 2006 | 1471 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2006 | 1419 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4462 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23338 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9583 | 0.010 |
Why?
|
Concepts
(276)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_